These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15903017)

  • 1. [Cardiovascular risks and cyclooxygenase-2 inhibitors].
    Letonturier P
    Presse Med; 2005 Apr; 34(7):548. PubMed ID: 15903017
    [No Abstract]   [Full Text] [Related]  

  • 2. Coxibs and cardiovascular risk.
    Zaidi SA
    CMAJ; 2005 Oct; 173(8):852-3. PubMed ID: 16217095
    [No Abstract]   [Full Text] [Related]  

  • 3. COX-2 selective drugs and cardiovascular risks: same data but discrepant conclusions?
    Bannwarth B
    Expert Opin Drug Saf; 2006 Jan; 5(1):1-2; author reply 1-2. PubMed ID: 16370948
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclooxygenase-2 inhibition and cardiovascular events.
    Pitt B; Pepine C; Willerson JT
    Circulation; 2002 Jul; 106(2):167-9. PubMed ID: 12105151
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiovascular risks of selective COX-2-inhibitors].
    Schrör K
    Dtsch Med Wochenschr; 2004 Dec; 129(49):2653-6. PubMed ID: 15578320
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclooxygenase 2 inhibitors.
    Kelley KW; Ramsey LA
    Adv Nurse Pract; 2003 Mar; 11(3):22-4. PubMed ID: 12683165
    [No Abstract]   [Full Text] [Related]  

  • 7. COX-2 inhibitors--second, do some good.
    Harrison A
    N Z Med J; 2005 Apr; 118(1212):U1395. PubMed ID: 15806191
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased risk of cardiovascular events with coxibs and NSAIDs.
    Scott DG; Watts RA
    Lancet; 2005 Apr 30-May 6; 365(9470):1537. PubMed ID: 15866299
    [No Abstract]   [Full Text] [Related]  

  • 9. [A step back or training pain?].
    Raeder J
    Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2050-1. PubMed ID: 16100553
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insights and views about cardiovascular safety of COX2 inhibitors].
    Wallentin L
    Lakartidningen; 2005 Feb 28-Mar 6; 102(9):666, 668, 671. PubMed ID: 15804041
    [No Abstract]   [Full Text] [Related]  

  • 11. COX-2 inhibitors: cancer prevention or cardiovascular risk?
    Senior K
    Lancet Oncol; 2005 Feb; 6(2):68. PubMed ID: 15704289
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on Jüni P, Dieppe P. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs.
    Stichtenoth DO; Frölich JC
    Age Ageing; 2004 Sep; 33(5):521. PubMed ID: 15315931
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclo-oxygenase-2-specific inhibitors and cardiovascular morbidity.
    Ruilope LM; Coca A; Banegas JR; Pablos JL; Luque M
    Curr Hypertens Rep; 2002 Aug; 4(4):261-4. PubMed ID: 12117452
    [No Abstract]   [Full Text] [Related]  

  • 14. Discontinuation of Vioxx.
    Nutt DJ
    Lancet; 2005 Jan 1-7; 365(9453):28. PubMed ID: 15639676
    [No Abstract]   [Full Text] [Related]  

  • 15. [VIOXX written off--and what next? COX-2 inhibitors and cardiovascular diseases].
    Jerie P
    Cas Lek Cesk; 2005; 144(1):4. PubMed ID: 15789774
    [No Abstract]   [Full Text] [Related]  

  • 16. Life without COX 2 inhibitors: risks and benefits are determined by dose and potency.
    Sánchez-Delgado EJ
    BMJ; 2006 Jun; 332(7555):1451-2. PubMed ID: 16777893
    [No Abstract]   [Full Text] [Related]  

  • 17. Valdecoxib withdrawal leaves pain relief treatment gap.
    Lang L
    Gastroenterology; 2005 Jun; 128(7):1769-70. PubMed ID: 15940608
    [No Abstract]   [Full Text] [Related]  

  • 18. COX-2 inhibitors and cardiovascular toxicity: a class effect?
    Laible B
    S D J Med; 2005 Mar; 58(3):93-4. PubMed ID: 15794479
    [No Abstract]   [Full Text] [Related]  

  • 19. Don't throw out the baby with the bathwater!
    Kamen B; Kieran M
    J Pediatr Hematol Oncol; 2005 Feb; 27(2):59-60. PubMed ID: 15701976
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences between COX-2-specific inhibitors: clinical and economic implications.
    Sonnenblick EH
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S428-30. PubMed ID: 12416792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.